Aller au contenu principal
Profil bibliographique

Geraldine Gueron

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

169Publications signalées
1296Citations signalées
5Affiliations récentes

Les institutions déclarées

Les domaines associés

Prostate Cancer Treatment and ResearchHeme Oxygenase-1 and Carbon MonoxideCancer, Hypoxia, and MetabolismEicosanoids and Hypertension PharmacologyBone health and treatments

Les publications récentes

Accès ouvert 2026 preprint OpenAlex

IFNγ at the crossroads of systemic protection and brain vulnerability to coronavirus infection

Agustina Ayelen Sabater, Ana Paula Arévalo, Paula Perbolianachis, Pablo Sanchis et autres

Abstract The COVID-19 pandemic, together with previous outbreaks caused by highly pathogenic coronaviruses, highlighted the importance of understanding the host determinants that influence pathogenesis, both to improve our understanding of disease mechanisms, and to strengthen preparedness for future outbreaks. In our previous …

us, ar, uy (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2026 preprint OpenAlex

STAG2 Maintains Chromatin Compartmentalization and Represses Regulatory Element Contact to Promote Oncogenic Signaling in Muscle Invasive Bladder Cancer

Sarah R. Athans, Jiaojiao Zhou, Xiaozhuo Liu, Eduardo Cortes Gomez et autres

ABSTRACT Contrary to other cancer types, stromal antigen 2 (STAG2) expression is associated with shorter survival and an invasive phenotype in muscle invasive bladder cancer (MIBC). As a cohesin complex component, STAG2 regulates genome organization and cell type-specific transcription, yet its mechanistic …

us, ar (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2026 article OpenAlex

Role of the cross-regulation between Wnt pathway activation and androgen receptor signaling in prostate cancer treatment resistance

Nicolás Anselmino, Pablo Sanchis, Juan Antonio Bizzotto, Estefanía Labanca et autres

Prostate cancer (PCa) is a biologically heterogeneous disease that frequently progresses to castration-resistant prostate cancer (CRPC), a challenging clinical stage. The underlying mechanisms driving CRPC progression and resistance to androgen receptor (AR) signaling inhibition (ARSI) remain incompletely understood. Emerging evidence implicates the …

us, es, ar (code pays fourni par la source)

0 citations Cell Death and Differentiation
2026 conference-abstract OpenAlex

Abstract 4740: Exploiting ketone body metabolism as a therapeutic vulnerability in prostate cancer

Pablo Sanchis, Agustina Ayelen Sabater, Jiabin Dong, Peter D.A. Shepherd et autres

Abstract 6 UT MD Anderson Cancer Ctr., Houston, TX.Prostate cancer (PCa) progression remains a major clinical challenge with limited therapeutic options, and the complexity of metabolic pathways fueling advanced PCa rests poorly understood. We have identified a shift from glycolysis to ketone …

ar, us (code pays fourni par la source)

0 citations Cancer Research
2026 conference-abstract OpenAlex

Abstract 6078: Integrating patient-derived systems to model metastatic prostate cancer and decode therapy resistance

Agustina Ayelen Sabater, Pablo Sanchis, Jun Yang, Jiabin Dong et autres

Abstract Prostate cancer (PCa) lethality is driven by treatment-refractory disease and skeletal metastases, yet progress in understanding these processes has been hindered by the lack of physiologically relevant models. To address this gap, we developed an integrated platform of MD Anderson PCa …

ar, us (code pays fourni par la source)

0 citations Cancer Research
2026 conference-abstract OpenAlex

Abstract 5908: PCGEM1 overload: Triggering lethal stress responses in castration-resistant prostate cancer

Sabrina Ledesma-Bazan, Pablo Sanchis, Rocio A. Seniuk, Gastón Pascual et autres

Abstract Metastatic castration-resistant prostate cancer (mCRPC) represents the most advanced stage of the disease, with no curative treatments. lncRNAs are emerging regulators of prostate cancer (PCa) biology and the lncRNA PCGEM1 has been linked to tumorigenesis and c-Myc activity in AR positive …

ar (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2025 article OpenAlex

Genetic characterization of pediatric B-cell acute lymphoblastic leukemia in Argentina uncovers molecular heterogeneity and novel variants

María Sol Ruiz, Ezequiel Jorge Sosa, Daniel Avendaño, Ignacio Gomez Mercado et autres

Introduction: Acute lymphoblastic leukemia is the most common childhood cancer, yet its diagnosis and risk classification remain incomplete in many regions due to limited access to molecular studies. Methods: We present the first comprehensive genetic and molecular characterization of childhood B-cell Acute …

ar (code pays fourni par la source)

2 citations Frontiers in Pharmacology
2025 conference-abstract OpenAlex

Abstract B003: Characterization of CD20 transcriptional diversity using short- and long-read sequencing in pediatric acute lymphoblastic leukemia: potential implications for rituximab plus chemotherapy treatment

María Sol Ruiz, Lucila Viappiani, Daniel Avendaño, Ignacio Gomez Mercado et autres

Abstract Randomized trials in adult patients have shown that rituximab, a monoclonal antibody targeting CD20 (MS4A1 gene), can improve treatment response in de novo Acute Lymphoblastic Leukemia (ALL). These findings have led to clinical trials incorporating rituximab into first-line chemotherapy for pediatric …

ar (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2025 article OpenAlex

PKA-driven SPP1 activation as a novel mechanism connecting the bone microenvironment to prostate cancer progression

Pablo Sanchis, Agustina Ayelen Sabater, Jimena Rada, Rocio A. Seniuk et autres

Prostate cancer (PCa) bone metastasis (BM) poses a significant clinical challenge due to the heterogeneity of treatment responses and patient outcomes. In this study, we examined the role of Protein Kinase A (PKA) signaling in modulating the expression of osteopontin (SPP1/OPN), a …

us, ar, es (code pays fourni par la source)

5 citations Oncogene
2025 conference-abstract OpenAlex

Abstract 1422: STAG2-mediated gene expression programs promote invasion in muscle invasive bladder cancer

Sarah R. Athans, Nithya S. Krishnan, Swathi Ramakrishnan, Aimee B. Stablewski et autres

Abstract Stromal antigen 2 (STAG2) is associated with worse overall and progression free survival of muscle invasive bladder cancer (MIBC) patients. Furthermore, STAG2 expression is associated with motility and invasiveness of MIBC cell in vitro, suggesting that STAG2 acts as an oncogene …

us, ar (code pays fourni par la source)

0 citations Cancer Research
2025 conference-abstract OpenAlex

Abstract 5657: Carbon monoxide-releasing molecules as top-notch candidates for prostate cancer therapy

Gastón Pascual, Pablo Sanchis, Agustina Ayelen Sabater, Rocio A. Seniuk et autres

Abstract Carbon monoxide (CO) is an endogenous gasotransmitter with proven anti-inflammatory, anti-apoptotic, and antiproliferative effects. CO-releasing molecules (CO-RMs) have been developed to deliver controlled doses of CO, differing in their CO-release kinetics and chemical structure, showing promise as therapeutic agents in various …

ar, us, fr (code pays fourni par la source)

0 citations Cancer Research
2025 conference-abstract OpenAlex

Abstract 2967: Bone voyage: FGFR1, stemness, and the Wnt trail to prostate cancer metastasis

Agustina Ayelen Sabater, Pablo Sanchis, Nicolás Anselmino, Juan Antonio Bizzotto et autres

Abstract Prostate cancer (PCa) lethality largely stems from the progression to castration-resistant PCa (CRPC) bone metastasis. We previously reported that fibroblast growth factor receptor 1 (FGFR1) is overexpressed in a subset of human CRPC bone metastases, and that FGFR1 overexpression of both …

ar, us (code pays fourni par la source)

0 citations Cancer Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.